New antibody tested on healthy people for first time
Knowledge-focused
Ongoing
This is an early safety study testing a new antibody drug called SM17. It involves 30 healthy Chinese adults to check for side effects and see how the body processes the drug when given as an injection under the skin or into a vein. The main goal is to gather basic safety informa…
Phase: PHASE1 • Sponsor: SinoMab BioScience Ltd • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC